Polymorphic microRNA-target interactions: a novel source of phenotypic variation.
1Unit of Animal Genomics, Department of Animal Production, Faculty of Veterinary Medicine & CBIG, University of Liège (B43), Liège, Belgium.
Cold Spring Harbor Symposia on Quantitative Biology
|March 27, 2007
Summary
A genetic mutation in Texel sheep GDF8 gene alters microRNA binding, reducing muscle growth inhibitors and causing muscular hypertrophy. This highlights microRNA target site polymorphisms
Area of Science:
- Genetics
- Molecular Biology
- Animal Science
Background:
- Muscular hypertrophy, or increased muscle mass, is a significant trait in livestock breeding.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression, particularly in muscle development.
- The GDF8 gene (Growth Differentiation Factor 8) is a key negative regulator of skeletal muscle mass.
Purpose of the Study:
- To investigate the genetic basis of muscular hypertrophy in Texel sheep using forward genetics.
- To identify the specific genetic alteration responsible for the enhanced muscle growth phenotype.
- To explore the role of microRNA interactions in regulating GDF8 expression and muscle mass.
Main Methods:
- Forward genetics approach to study muscular hypertrophy in Texel sheep.
- Identification of genetic mutations using sequencing, focusing on the GDF8 gene.
- Analysis of microRNA binding sites within the GDF8 gene's 3' untranslated region (3'UTR).
- Validation of miRNA-target interactions and gene expression analysis.
Main Results:
- An A-to-G transition mutation was identified in the 3'UTR of the GDF8 gene in Texel sheep.
- This mutation creates an illegitimate target site for muscle-expressed microRNAs (miR-1 and miR-206).
- The altered miRNA binding leads to down-regulation of GDF8, a muscle-specific chalone, resulting in muscular hypertrophy.
Conclusions:
- The identified GDF8 mutation is a key driver of muscular hypertrophy in Texel sheep via altered miRNA regulation.
- Polymorphisms in miRNA target sites are common in mammals and can influence phenotypic variation.
- These findings suggest that miRNA target site variations may play a role in disease and phenotypic diversity, necessitating further research and tools like the Patrocles database.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
piRNA - Piwi-interacting RNAs
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


